Results 191 to 200 of about 1,379,300 (228)
Some of the next articles are maybe not open access.

Targeted toxins in pain

Advanced Drug Delivery Reviews, 2003
Although only recently applied to the study of nociception, 'molecular neurosurgery', producing highly selective neural lesions using targeted cytotoxins, has proven a valuable tool for analysis of nociceptive systems and promises to yield much more information on the role of specific types of neurons in pain perception and possibly new pain therapies.
Ronald G, Wiley, Douglas A, Lappi
openaire   +2 more sources

Targeting Bacterial Toxins

Angewandte Chemie International Edition, 2012
AbstractProtein toxins constitute the main virulence factors of several species of bacteria and have proven to be attractive targets for drug development. Lead candidates that target bacterial toxins range from small molecules to polymeric binders, and act at each of the multiple steps in the process of toxin‐mediated pathogenicity.
Ivarsson ME, Leroux JC, Castagner B
openaire   +3 more sources

Clinical Trials of Targeted Toxins

Seminars in Cancer Biology, 1995
Immunotoxins (monoclonal antibodies chemically coupled to peptide toxins) and fusion toxins (peptide ligands fused genetically to peptide toxins) have been used to treat a variety of malignancies over the last 20 years. Problems with normal tissue toxicities (vascular leak syndrome, hepatotoxicity, and neurotoxicities), poor penetration to tumor ...
Edward P Tagge   +2 more
exaly   +3 more sources

Diphtheria Toxin-Based Targeted Toxins That Target Glioblastoma Multiforme

Toxin Reviews, 2014
AbstractTargeted toxins (TTs) are compounds that bind cell surface receptors overexpressed on cancer cells. After the molecule enters the cell, the toxin component migrates to the ribosomes where it blocks protein synthesis killing the cell. Most of these proteins are recombinant and contain a carrier ligand or antibody attached to a modified bacterial
Daniel A Vallera, Yan Michael Li
exaly   +2 more sources

Targeted toxins

Journal of Oncology Pharmacy Practice, 1999
Objective. Current modalities used in the treatment of cancer often cause unacceptable damage to normal tissue. Toxins targeted toward tumor cells by antibodies or growth factors have the potential to selectively kill tumor cells while leaving normal tissue intact.
M W J den Brok   +3 more
openaire   +1 more source

Diphtheria toxin-based targeted toxin therapy for brain tumors

Journal of Neuro-Oncology, 2013
Targeted toxins (TT) are molecules that bind cell surface antigens or receptors such as the transferrin or interleukin-13 receptor that are overexpressed in cancer. After internalization, the toxin component kills the cell. These recombinant proteins consist of an antibody or carrier ligand coupled to a modified plant or bacterial toxin such as ...
Yan Michael, Li   +2 more
openaire   +2 more sources

Peptide Toxins Targeting KV Channels

2021
A number of peptide toxins isolated from animals target potassium ion (K+) channels. Many of them are particularly known to inhibit voltage-gated K+ (KV) channels and are mainly classified into pore-blocking toxins or gating-modifier toxins. Pore-blocking toxins directly bind to the ion permeation pores of KV channels, thereby physically occluding them.
Kazuki, Matsumura   +2 more
openaire   +2 more sources

Targeted toxins as anticancer agents

Cancer, 1994
Transformed cells, such as those found in breast cancer, often overexpress a variety of cell surface receptors and antigens. Antibodies or growth factors that specifically recognize these membrane-bound structures can be linked with protein toxins, resulting in cell-specific cytotoxic reagents.
openaire   +2 more sources

Targeted Toxin Therapy for the Treatment of Cancer

JNCI Journal of the National Cancer Institute, 1989
Protein toxins such as Pseudomonas exotoxin, diphtheria toxin, and ricin may be useful in cancer therapy because they are among the most potent cell-killing agents. One molecule of a toxin delivered to the cytoplasm of a cancer cell will be lethal for that cell.
D, FitzGerald, I, Pastan
openaire   +2 more sources

Targeted toxins.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2000
Targeted toxins, consisting of tumor-selective ligands coupled to polypeptide toxins, represent a new class of cancer therapeutics that kills malignant cells by inactivating cytosolic protein synthesis and inducing apoptosis. A number of these molecules have been produced under good manufacturing practice conditions and given systemically to patients ...
A E, Frankel   +2 more
openaire   +1 more source

Home - About - Disclaimer - Privacy